Contract pharmaceutical manufacturer IDT Australia has announced a strategic realignment to sharpen its operational focus, deliver $1 million in annualised cost savings from the financial year 2026, and position the business for more sustainable growth. …
IDT Australia sharpens strategy with cost savings and radiopharmaceutical focus
October 21, 2025 Latest NewsBioPharma
Latest Video
New Stories
-
IDT Australia sharpens strategy with cost savings and radiopharmaceutical focus
October 21, 2025 - - Latest News -
FOI reforms set back transparency decades and will impact public health decision-making
October 21, 2025 - - Latest News -
Astellas' XTANDI achieves landmark survival milestone in prostate cancer
October 21, 2025 - - Latest News -
Services Australia reports record number of processed PBS prescriptions
October 21, 2025 - - Latest News -
Endometriosis diagnoses in Australian GP clinics nearly double over a decade
October 21, 2025 - - Latest News -
'Patient-centric partnerships will unlock brighter and more equitable outcomes for all'
October 21, 2025 - - Latest News -
Vaccine confidence slips as Australians grow more concerned about access to healthcare
October 20, 2025 - - Latest News